Unlock this StockReport nowClick to Unlock

BioPharma Credit Share Price

BPCR $1.02 0.0  0.0%
4:35pm 5.00k
StockRank

Momentum
Relative Strength (%)
1m
3m
1yr
Volume Change (%)
10d v 3m
Price vs... (%)
52w High
50d MA
200d MA
vs.
market
vs.
industry
Growth & Value
12m Forecast Rolling
PE Ratio (ttm) 14.4
PEG Ratio (ttm)
EPS Growth (ttm) %
Dividend Yield (ttm) %
Valuation (ttm)
Price to Book Value 1.02
Price to Tang. Book
Price to Free Cashflow
Price to Sales
EV to EBITDA
Margin of Safety (beta)
Screens Passed
Balance Sheet · Income Statement · Cashflow Financial Summary
Year End 31st Dec 2013 2014 2015 2016 2017 2018 2019E 2020E CAGR / Avg
Revenue $m
Operating Profit $m
Net Profit $m
EPS Reported $
EPS Normalised $
EPS Growth %
PE Ratio x
PEG x
Profitability
Operating Margin %
ROA %
ROCE %
ROE %
Cashflow
Op. Cashflow ps $
Capex ps $
Free Cashflow ps $
Last ex-div: 15th Aug, paid: 20th Sep more... Dividends
Dividend ps $
Dividend Growth %
Dividend Yield %
Dividend Cover x
Balance Sheet
Cash etc $m
Working Capital $m
Net Fixed Assets $m
Net Debt $m
Book Value $m
Average Shares m
Book Value ps $ -0.5%

FINANCIAL BRIEF: For the fiscal year ended 31 December 2018, Biopharma Credit PLC revenues increased from $39.3M to $97.3M. Net income increased from $31.7M to $70.1M. Revenues reflect Investment income increase from $33.2M to $92.1M, Other income increase of 21% to $4.6M. Net income was partially offset by Legal & professional fees increase from $483K to $3M (expense), Other expenses increase of 84% to $486K (expense). more »

Health Trend
Bankruptcy Risk
  Earnings Manipulation Risk
Magic Formula Score
Other Ratios
Leverage (ttm) Total -Intang +Pension
Gross Gearing %
Net Gearing %
Cash / Assets %
vs.
market
vs.
industry
Recent History
Latest interim period (ended 31st Dec '18) vs. prior year
Sales Growth %
EPS Growth %
3yr Compound Annual Growth Rate
Sales Growth %
EPS Growth %
DPS Growth %

Broker Forecasts
31st Dec 2019
31st Dec 2020

Price Target: N/A
Net Profit EPS DPS Net Profit EPS DPS
Est. Long Term Growth Rate: n/a (£) (£) (£) (£) (£) (£)
Consensus Estimate
1m Change
3m Change
Broker Consensus Trend
Broker Recommendations for BioPharma Credit
Recommendation:Strong SellSellHoldBuyStrong Buy
No. of Analysts: 0 0 2 0 0

Named Brokers and Analysts
Stifel Nicolaus and Company, Incorporated Sachin Saggar , Jefferies Matthew Hose ,

Profile Summary

BioPharma Credit Plc is a closed-ended investment company. The Company's investment objective is to generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry. The Company may acquire debt assets from a company operating in the life sciences industry or an entity other than a life sciences company, which directly or indirectly holds an interest in royalty rights to certain products, including any investment vehicle or special purpose vehicle. The Company's un-invested capital may be invested in cash instruments or bank deposits for cash management purposes. The Company may, from time to time, enter into such hedging or other derivative arrangements. The Company's investment manager is Pharmakon Advisors L.P.

Directors: Jeremy Sillem (CHM) , Colin Bond (DRC) 57, Duncan Budge (DRC) 61, Harry Hyman (DRC) , Stephanie Leouzon (NED) ,

No. of Employees: n/a No. of Shareholders: n/a


Last Annual December 31st, 2018
Last Interim December 31st, 2018
Incorporated October 24, 2016
Public Since March 27, 2017
Shares in Issue 1,373,932,067
Free Float 1.15bn (83.9%)
Sector Financials
Industry Collective Investments
Index
Exchange London Stock Exchange (Full)
Eligible for an ISA? a SIPP?

BPCR Share Price Performance BPCR Share Price Quote
$1.02
0.0  0.0%
Traded 4:35pm · Minimum 15 min delayed · NMS: 5.00k

Latest BPCR News Announcements (delayed)

Upcoming BPCR Events
Wednesday 4th September, 2019
Half Year 2019 BioPharma Credit PLC Earnings Call
Wednesday 4th September, 2019
Half Year 2019 BioPharma Credit PLC Earnings Release

Recent ↓
Thursday 15th August, 2019
Dividend For BPCR.L
Thursday 23rd May, 2019
Dividend For BPCR.L
Tuesday 5th March, 2019
Full Year 2018 BioPharma Credit PLC Earnings Release
Thursday 28th February, 2019
Dividend For BPCR.L
Thursday 28th February, 2019
Dividend For BPCR.L
Thursday 1st November, 2018
Dividend For BPCR.L
Thursday 27th September, 2018
Half Year 2018 BioPharma Credit PLC Earnings Release
Thursday 30th August, 2018
Dividend For BPCR.L
Thursday 31st May, 2018
Dividend For BPCR.L
Thursday 8th March, 2018
Dividend For BPCR.L
Thursday 8th March, 2018
Dividend For BPCR.L
Thursday 14th December, 2017
Dividend For BPCR.L


Use of our data service is subject to express Terms of Service. Please see our full site disclaimer for more details. In particular, it is very important to do your own research (DYOR) and seek professional advice before making any investment based on your own personal circumstances. Please note that the information, data and analysis contained within this stock report: (a) include the proprietary information of Stockopedia's third party licensors and Stockopedia; (b) should not be copied or redistributed except as specifically authorised; and (c) are not warranted to be complete, accurate or timely. You should independently research and verify any information that you find in this report. Stockopedia will not be liable in respect of any loss, trading or otherwise, that you may suffer arising out of such information or any reliance you may place upon it. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up. © Stockopedia 2019.


Should you buy BPCR

Access BPCR Analytics Now!

FREE TRIAL or TAKE THE TOUR
Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis